# A pH-driven receptor switch from ACE2 to NPC1 enables endosomal entry of SARS-CoV-2

**Authors:** Yong-Hui Zheng, Zhongshun Liu, Yu Pang, Ilyas Khan, Li Ou, Yixiang Hu, Sunan Li, Justin Richner, Tongqing Zhou

PMC · DOI: 10.21203/rs.3.rs-8437418/v1 · Research Square · 2026-03-04

## TL;DR

The study shows that SARS-CoV-2 switches from using ACE2 to NPC1 as a receptor during endosomal entry, depending on pH levels.

## Contribution

The novel contribution is the discovery of a pH-dependent receptor switch from ACE2 to NPC1 during SARS-CoV-2 endosomal entry.

## Key findings

- NPC1 is an essential intracellular receptor for spike-mediated fusion in acidic endosomes.
- Omicron variant shows increased dependence on NPC1 for endosomal entry.
- NPC1 binds with higher affinity to the spike protein under acidic conditions compared to ACE2.

## Abstract

SARS-CoV-2 enters cells either by TMPRSS2-mediated fusion at the cell surface or by cathepsin-dependent fusion from late endosomes, yet how spike remains competent for fusion during endocytic trafficking is unclear. Here we identify Niemann–Pick C1 (NPC1) as an essential intracellular receptor that enables spike-mediated fusion in acidic late endosomes/lysosomes. Genetic ablation or pharmacological inhibition of NPC1 selectively blocked endosomal entry but not the surface entry, and Omicron showed heightened NPC1 dependence consistent with reduced fusogenicity and preferential endosomal entry in cell culture. A bimolecular fluorescence complementation assay localized spike–NPC1 complexes to Rab7/LAMP1-positive compartments. Biochemical and competition analyses, supported by structural modelling, revealed that NPC1 loop C engages a surface on the receptor-binding domain distinct from the ACE2 interface and binds with higher affinity under acidic conditions, whereas ACE2 binding is favored at neutral pH. These findings define a pH-driven receptor switch from ACE2 to NPC1 during endocytic entry.

## Linked entities

- **Genes:** ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272], NPC1 (NPC intracellular cholesterol transporter 1) [NCBI Gene 4864], TMPRSS2 (transmembrane serine protease 2) [NCBI Gene 7113], RAB7A (RAB7A, member RAS oncogene family) [NCBI Gene 7879], LAMP1 (lysosome associated membrane protein 1) [NCBI Gene 3916]
- **Proteins:** cathepsin (cathepsin), ACE2 (angiotensin converting enzyme 2), NPC1 (NPC intracellular cholesterol transporter 1), RAB7A (RAB7A, member RAS oncogene family), LAMP1 (lysosome associated membrane protein 1)

## Full-text entities

- **Genes:** LAMP1 (lysosome associated membrane protein 1) [NCBI Gene 3916] {aka CD107a, LAMPA, LGP120}, NPC1 (NPC intracellular cholesterol transporter 1) [NCBI Gene 4864] {aka NPC, POGZ, SLC65A1}, S (surface glycoprotein) [NCBI Gene 43740568] {aka spike glycoprotein}, ACE2 (angiotensin converting enzyme 2) [NCBI Gene 59272] {aka ACEH}, RAB7B (RAB7B, member RAS oncogene family) [NCBI Gene 338382] {aka RAB7}, TMPRSS2 (transmembrane serine protease 2) [NCBI Gene 7113] {aka PRSS10}
- **Species:** Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12997109/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12997109/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC12997109/full.md

---
Source: https://tomesphere.com/paper/PMC12997109